Evidence map›Paper›PMID 39191399›Full record

ArticleMicrobiology spectrum2024

Effective biofilm eradication in MRSA isolates with aminoglycoside-modifying enzyme genes using high-concentration and prolonged gentamicin treatment.

Kohei Ando, Satoshi Miyahara, Shuhei Hanada, Kazumasa Fukuda, Mitsumasa Saito, Akinori Sakai, Akihiro Maruo, Yukichi Zenke

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kohei AndoDepartment of Emergency and Intensive Care Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Satoshi MiyaharaDepartment of Microbiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.ORCID 0000-0001-8522-860X
Shuhei HanadaDepartment of Microbiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kazumasa FukudaDepartment of Microbiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.ORCID 0000-0001-6126-6118
Mitsumasa SaitoDepartment of Microbiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Akinori SakaiDepartment of Orthopedic Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Akihiro MaruoDepartment of Orthopedic Surgery, Hyogo Prefectural Harima-Himeji General Medical Center, Himeji, Japan.
Yukichi ZenkeDepartment of Emergency and Intensive Care Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Funding

MEXT | Japan Society for the Promotion of Science (JSPS) 21K09241
6 · The paper itself

Abstract

Bone and soft tissue infections caused by biofilm-forming bacteria, such as methicillin-resistant IMPORTANCE: Our analysis of 101 MRSA clinical isolates has provided valuable insights that could enhance treatment selection for biofilm infections in orthopedics. We found that high concentrations of gentamicin were effective against MRSA biofilms, and even prolonged exposure to concentrations lower than the minimum biofilm eradication concentration (MBEC) value could eliminate biofilms. The presence of the

Indexed as

AminoglycosidesAnti-Bacterial AgentsBiofilmsGentamicinsMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcal InfectionsBacterial ProteinsDrug Resistance, BacterialHumansJapanAminoglycosidesAnti-Bacterial AgentsBacterial ProteinsGentamicinsaminoglycoside-modifying enzyme genesbiofilmgentamicinminimal biofilm eradication concentration (MBEC)MRSA

Identifiers

PMID39191399
PMCPMC11448082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.